Skip to main content
  • Vancouver
  • Boston
  • Seattle
Hit enter to search or ESC to close
Close Search
Science in Vancouver
search
Menu
  • Jobs
  • Events
  • Resources
    • An Insider’s Guide to Vancouver
    • Funding Opportunities
    • Local Science Groups
    • Newsletter Archive
    • Vancouver Seminar Series
  • Submit
    • Submit a Job
    • Submit an Article
    • Submit an Event
  • Subscribe Now
  • search
1234567/7

All Articles

  • All Articles

  • Publications of the Week

  • Local News

  • Spotlight

  • Interesting Articles

  • Your Voice

  • Awards

Clinical trial
Local News

Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-Cancer Immune Response in Colon Cancer

LifeSciences BC | August 20, 2020
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed…
eabramovichAugust 20, 2020
Read More
Tumor cancer
Local News

Researchers Identify Mutation Associated with Improved Survival in Diffuse Large B-Cell Lymphoma

Terry Fox Research Institute | August 19, 2020
In a paper published in Nature Medicine (April 2020), the team led by Drs. David Scott and…
sciencecityAugust 19, 2020
Read More
ATP
Local News

Fast and Loose: Nanomachines with Floppy Connections Go Faster

SFU News | August 19, 2020
Converting energy quickly and efficiently is critical to both human-engineered machinery, and to the microscopic…
sciencecityAugust 19, 2020
Read More
Arshad and Lu
Local News

Perspectives, Possibilities, and Community: Welcome to Neuropsyched!

Djavad Mowafaghian Centre for Brain Health | August 18, 2020
Neuropsyched is an online science communication platform in the format of a digital magazine, created by…
eabramovichAugust 18, 2020
Read More
Drugs
Local News

BOLD-100 Significantly Outperforms Remdesivir Head-to-Head in SARS-CoV-2 Model

Bold Therapeutics | August 18, 2020
Bold Therapeutics, a clinical-stage biopharmaceutical company, recently generated additional data supporting rapid clinical development of…
sciencecityAugust 18, 2020
Read More
Canadian flag
Interesting Articles

Government of Canada Invests $140 Million, Appointing World-Class Researchers as New or Renewed Canada Research Chairs

Government of Canada | August 18, 2020
In its 20th year, the Canada Research Chairs Program continues to provide opportunities for researchers…
sciencecityAugust 18, 2020
Read More
Chris Von Seggern
Local News

Xenon Pharmaceuticals Appoints Dr. Chris Von Seggern as Chief Commercial Officer

Xenon Pharmaceuticals | August 17, 2020
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced today the appointment of Dr. Chris Von Seggern as…
sciencecityAugust 17, 2020
Read More
Torsten Nielsen
Publications of the Week

The Epigenomics of Sarcoma

Nacev, B.A., et al. | August 17, 2020
Epigenetic regulation is critical to physiological control of development, cell fate, cell proliferation, genomic integrity…
eabramovichAugust 17, 2020
Read More
  • « Previous
  • 1
  • …
  • 426
  • 427
  • 428
  • 429
  • 430
  • …
  • 671
  • Next »

Brought to you by

  • x-twitter
  • bluesky
  • facebook
  • linkedin
  • About Science in Vancouver
  • Contact Us
  • Media Partnerships
  • Privacy
  • Cookie Preferences
  • Subscribe

SCIENCE IN THE CITY is an official mark of McMaster University and it is used and registered by STEMCELL Technologies Canada Inc. in Canada with the consent of McMaster University.

Close Menu
Subscribe Now
  • Jobs
  • Events
  • Resources
    • An Insider’s Guide to Vancouver
    • Funding Opportunities
    • Local Science Groups
    • Newsletter Archive
    • Vancouver Seminar Series
  • Submit
    • Submit a Job
    • Submit an Article
    • Submit an Event
  • Vancouver
  • Boston
  • Seattle